News
The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...
8d
MedPage Today on MSNCDC Follows Advice of Ousted Vaccine Panel, Expands Access to RSV ShotThe new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...
A 58-year-old female from metropolitan Adelaide is in a critical condition in hospital, after being diagnosed with invasive meningococcal disease. The ...
The Opposition has renewed calls to fund the B strain of the meningococcal vaccine after six out of the seven recorded cases ...
Since the rollout of the conjugate MenC vaccine in 2001 and the MenACWY in 2018, rates of invasive meningococcal disease have dropped dramatically, from 684 cases in 2002, to 136 cases in 2024.
Since the rollout of the conjugate MenC vaccine in 2001 and the MenACWY in 2018, rates of invasive meningococcal disease have dropped dramatically, from 684 cases in 2002, to 136 cases in 2024.
Fast-forward a few more years and analysts predict that the meningococcal disease vaccine market size will continue its impressive upward trajectory-expected to expand to $3.83 billion by 2029 at ...
US CDC Accepts Ousted Vaccine Panel's Recommendations for RSV, Meningococcal Shots (Reuters) -The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of ...
GSK is currently the market leader in the meningococcal vaccine market, racking up sales of £1.26 billion (almost $1.6 billion) last year across the Bexsero and Menveo brands, but is having to ...
The 17 members of the CDC's vaccine advisory committee, who were ousted last week, argued their abrupt dismissal has "left ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results